This clinical study will evaluate the short-term (1 year) and long-term (5 and 10 year) safety and effectiveness of the Journey II CR Total Knee System in patients with degenerative joint disease of the knee requiring primary total knee replacement.
Please use this link for further information:
Primary Investigator: Michael Swank